Enviar artigo por via de e-mail Effect of Fibroblast-Like Cells of Mesenchymal Origin of Cytotoxic Activity of Lymphocytes against NK-Sensitive Target Cells
- Autores: Lupatov A.1,2, Kim Y.1,2, Bystrykh O.2, Vakhrushev I.1,2, Pavlovich S.2, Yarygin K.1,2, Sukhikh G.1,2
-
Afiliações:
- V. N. Orekhovich Research Institute of Biomedical Chemistry
- V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation
- Edição: Volume 162, Nº 4 (2017)
- Páginas: 552-557
- Seção: Translated from Kletochnye Tekhnologii v Biologii i Meditsine (Cell Technologies in Biology and Medicine)
- URL: https://journals.rcsi.science/0007-4888/article/view/238371
- DOI: https://doi.org/10.1007/s10517-017-3658-5
- ID: 238371
Citar
Acesso aberto
Acesso está concedido
Somente assinantes
Resumo
We studied immunosuppressive properties of skin fibroblasts and mesenchymal stromal cells against NK cells. In vitro experiments showed that mesenchymal stromal cells isolated from human umbilical cord and human skin fibroblasts can considerably attenuate cytotoxic activity of NK cells against Jurkat cells sensitive to NK-mediated lysis. NK cells cultured in lymphocyte population exhibited higher cytotoxic activity than isolated NK cells. Mesenchymal stromal cells or fibroblasts added 1:1 to lymphocyte culture almost completely suppressed NK cell cytotoxicity. This suggests that fibroblast-like cells can suppress not only isolated NK cells, but also NK cells in natural cell microenvironment.
Sobre autores
A. Lupatov
V. N. Orekhovich Research Institute of Biomedical Chemistry; V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation
Autor responsável pela correspondência
Email: alupatov@inbox.ru
Rússia, Moscow; Moscow
Ya. Kim
V. N. Orekhovich Research Institute of Biomedical Chemistry; V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation
Email: alupatov@inbox.ru
Rússia, Moscow; Moscow
O. Bystrykh
V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation
Email: alupatov@inbox.ru
Rússia, Moscow
I. Vakhrushev
V. N. Orekhovich Research Institute of Biomedical Chemistry; V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation
Email: alupatov@inbox.ru
Rússia, Moscow; Moscow
S. Pavlovich
V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation
Email: alupatov@inbox.ru
Rússia, Moscow
K. Yarygin
V. N. Orekhovich Research Institute of Biomedical Chemistry; V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation
Email: alupatov@inbox.ru
Rússia, Moscow; Moscow
G. Sukhikh
V. N. Orekhovich Research Institute of Biomedical Chemistry; V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation
Email: alupatov@inbox.ru
Rússia, Moscow; Moscow
